6CDU image
Entry Detail
PDB ID:
6CDU
Title:
Crystal structure of a chimeric human alpha1GABAA receptor in complex with alphaxalone
Biological Source:
PDB Version:
Deposition Date:
2018-02-09
Release Date:
2018-08-22
Method Details:
Experimental Method:
Resolution:
3.45 Å
R-Value Free:
0.28
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:chimeric alpha1GABAA receptor
Chain IDs:A, B, C, D, E, F, G, H, I, J
Chain Length:324
Number of Molecules:10
Biological Source:Dickeya dadantii (strain 3937), Homo sapiens
Ligand Molecules
Primary Citation
Structural basis of neurosteroid anesthetic action on GABAAreceptors.
Nat Commun 9 3972 3972 (2018)
PMID: 30266951 DOI: 10.1038/s41467-018-06361-4

Abstact

Type A γ-aminobutyric acid receptors (GABAARs) are inhibitory pentameric ligand-gated ion channels in the brain. Many anesthetics and neurosteroids act through binding to the GABAAR transmembrane domain (TMD), but the structural basis of their actions is not well understood and no resting-state GABAAR structure has been determined. Here, we report crystal structures of apo and the neurosteroid anesthetic alphaxalone-bound desensitized chimeric α1GABAAR (ELIC-α1GABAAR). The chimera retains the functional and pharmacological properties of GABAARs, including potentiation, activation and desensitization by alphaxalone. The apo-state structure reveals an unconventional activation gate at the intracellular end of the pore. The desensitized structure illustrates molecular determinants for alphaxalone binding to an inter-subunit TMD site. These structures suggest a plausible signaling pathway from alphaxalone binding at the bottom of the TMD to the channel gate in the pore-lining TM2 through the TM1-TM2 linker. The study provides a framework to discover new GABAAR modulators with therapeutic potential.

Legend

Protein

Chemical

Disease

Primary Citation of related structures